25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VERA (Vera Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Vera Therapeutics Inc together

I guess you are interested in Vera Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Vera Therapeutics Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Vera Therapeutics Inc’s Price Targets

I'm going to help you getting a better view of Vera Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vera Therapeutics Inc

I send you an email if I find something interesting about Vera Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Vera Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Vera Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$7.34
Expected worth in 1 year
$9.54
How sure are you?
26.3%

+ What do you gain per year?

Total Gains per Share
$2.20
Return On Investment
8.4%

For what price can you sell your share?

Current Price per Share
$26.34
Expected price per share
$23.81 - $33.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vera Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$26.34
Intrinsic Value Per Share
$-42.04 - $-49.73
Total Value Per Share
$-34.70 - $-42.39

2.2. Growth of Vera Therapeutics Inc (5 min.)




Is Vera Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$468.2m$226.7m$240.6m51.5%

How much money is Vera Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$54.5m-$26.9m-$27.6m-50.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Vera Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#126 / 853

Most Revenue
#825 / 853

Most Profit
#775 / 853

Most Efficient
#176 / 853
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vera Therapeutics Inc?

Welcome investor! Vera Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Vera Therapeutics Inc.

First you should know what it really means to hold a share of Vera Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Vera Therapeutics Inc is $26.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vera Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vera Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $7.34. Based on the TTM, the Book Value Change Per Share is $0.55 per quarter. Based on the YOY, the Book Value Change Per Share is $0.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vera Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.20-4.6%-0.86-3.2%-0.42-1.6%-0.25-1.0%-0.25-1.0%-0.25-1.0%
Usd Book Value Change Per Share-1.05-4.0%0.552.1%0.732.8%0.451.7%0.391.5%0.391.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.05-4.0%0.552.1%0.732.8%0.451.7%0.391.5%0.391.5%
Usd Price Per Share23.56-33.52-27.10-25.58-21.12-21.12-
Price to Earnings Ratio-4.91--10.75--15.45--10.42--14.11--14.11-
Price-to-Total Gains Ratio-22.54--30.55--43.91--40.03--46.65--46.65-
Price to Book Ratio3.21-5.13-7.89-7.62-8.23-8.23-
Price-to-Total Gains Ratio-22.54--30.55--43.91--40.03--46.65--46.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share26.34
Number of shares37
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.550.39
Usd Total Gains Per Share0.550.39
Gains per Quarter (37 shares)20.3514.29
Gains per Year (37 shares)81.4057.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10817105747
201631520114104
302442330171161
403263140229218
504073950286275
604884760343332
705705570400389
806516380457446
907337190514503
1008148000572560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.017.00.010.5%2.017.00.010.5%2.017.00.010.5%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.014.00.026.3%5.014.00.026.3%5.014.00.026.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.019.00.0%0.00.019.00.0%0.00.019.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.014.00.026.3%5.014.00.026.3%5.014.00.026.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vera Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.0450.550-290%0.734-242%0.453-331%0.386-371%0.386-371%
Book Value Per Share--7.3377.323+0%3.552+107%4.253+73%2.950+149%2.950+149%
Current Ratio--16.91821.007-19%15.898+6%14.681+15%15.103+12%15.103+12%
Debt To Asset Ratio--0.1910.162+17%0.262-27%0.236-19%0.470-59%0.470-59%
Debt To Equity Ratio--0.2350.197+20%0.386-39%0.333-29%0.252-6%0.252-6%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--1950262372.0002588554614.750-25%1941387210.750+0%1887916603.417+3%1714062484.235+14%1714062484.235+14%
Eps---1.199-0.855-29%-0.422-65%-0.255-79%-0.251-79%-0.251-79%
Ev To Ebitda Ratio---6.580-13.125+99%-17.482+166%-13.940+112%-20.107+206%-20.107+206%
Free Cash Flow Per Share---0.862-0.828-4%-0.418-51%-0.525-39%-0.397-54%-0.397-54%
Free Cash Flow To Equity Per Share---0.5440.537-201%0.777-170%0.498-209%0.466-217%0.466-217%
Gross Profit Margin--1.0001.0000%1.010-1%1.0030%1.0020%1.0020%
Intrinsic Value_10Y_max---49.728----------
Intrinsic Value_10Y_min---42.037----------
Intrinsic Value_1Y_max---2.520----------
Intrinsic Value_1Y_min---2.474----------
Intrinsic Value_3Y_max---9.449----------
Intrinsic Value_3Y_min---8.983----------
Intrinsic Value_5Y_max---18.641----------
Intrinsic Value_5Y_min---17.140----------
Market Cap1681116258.000+11%1503686372.0002139210864.750-30%1729462710.750-13%1632450686.750-8%1348225275.368+12%1348225275.368+12%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio3.590+11%3.2115.128-37%7.888-59%7.618-58%8.230-61%8.230-61%
Pe Ratio-5.492-12%-4.912-10.747+119%-15.453+215%-10.420+112%-14.114+187%-14.114+187%
Price Per Share26.340+11%23.56033.518-30%27.098-13%25.578-8%21.124+12%21.124+12%
Price To Free Cash Flow Ratio-7.641-12%-6.834-10.543+54%-15.722+130%-13.099+92%-18.661+173%-18.661+173%
Price To Total Gains Ratio-25.196-12%-22.537-30.555+36%-43.907+95%-40.029+78%-46.651+107%-46.651+107%
Quick Ratio--31.85139.035-18%28.900+10%26.217+21%22.536+41%22.536+41%
Return On Assets---0.132-0.102-23%-0.103-22%-0.125-6%-0.153+15%-0.153+15%
Return On Equity---0.163-0.124-24%-0.149-9%-0.173+6%-0.142-13%-0.142-13%
Total Gains Per Share---1.0450.550-290%0.734-242%0.453-331%0.386-371%0.386-371%
Usd Book Value--468277000.000467372250.000+0%226700750.000+107%271429166.667+73%188296789.474+149%188296789.474+149%
Usd Book Value Change Per Share---1.0450.550-290%0.734-242%0.453-331%0.386-371%0.386-371%
Usd Book Value Per Share--7.3377.323+0%3.552+107%4.253+73%2.950+149%2.950+149%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--1950262372.0002588554614.750-25%1941387210.750+0%1887916603.417+3%1714062484.235+14%1714062484.235+14%
Usd Eps---1.199-0.855-29%-0.422-65%-0.255-79%-0.251-79%-0.251-79%
Usd Free Cash Flow---55006000.000-52855000.000-4%-26698000.000-51%-33491833.333-39%-25317368.421-54%-25317368.421-54%
Usd Free Cash Flow Per Share---0.862-0.828-4%-0.418-51%-0.525-39%-0.397-54%-0.397-54%
Usd Free Cash Flow To Equity Per Share---0.5440.537-201%0.777-170%0.498-209%0.466-217%0.466-217%
Usd Market Cap1681116258.000+11%1503686372.0002139210864.750-30%1729462710.750-13%1632450686.750-8%1348225275.368+12%1348225275.368+12%
Usd Price Per Share26.340+11%23.56033.518-30%27.098-13%25.578-8%21.124+12%21.124+12%
Usd Profit---76531000.000-54570500.000-29%-26962500.000-65%-36050083.333-53%-28425631.579-63%-28425631.579-63%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---1.0450.550-290%0.734-242%0.453-331%0.386-371%0.386-371%
 EOD+5 -3MRQTTM+7 -25YOY+13 -203Y+14 -195Y+16 -1710Y+16 -17

3.3 Fundamental Score

Let's check the fundamental score of Vera Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.492
Price to Book Ratio (EOD)Between0-13.590
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than131.851
Current Ratio (MRQ)Greater than116.918
Debt to Asset Ratio (MRQ)Less than10.191
Debt to Equity Ratio (MRQ)Less than10.235
Return on Equity (MRQ)Greater than0.15-0.163
Return on Assets (MRQ)Greater than0.05-0.132
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Vera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.558
Ma 20Greater thanMa 5023.452
Ma 50Greater thanMa 10022.446
Ma 100Greater thanMa 20022.654
OpenGreater thanClose25.070
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Vera Therapeutics Inc

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Fundamental data was last updated by Penke on 2025-09-05 10:53:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vera Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--86.1%+86.1%
TTM--169.5%+169.5%
YOY--209.8%+209.8%
3Y--284.5%+284.5%
5Y--380.6%+380.6%
10Y--519.5%+519.5%
4.3.1.2. Return on Assets

Shows how efficient Vera Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • -13.2% Return on Assets means that Vera Therapeutics Inc generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vera Therapeutics Inc:

  • The MRQ is -13.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.2%TTM-10.2%-3.0%
TTM-10.2%YOY-10.3%+0.1%
TTM-10.2%5Y-15.3%+5.0%
5Y-15.3%10Y-15.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-12.1%-1.1%
TTM-10.2%-12.0%+1.8%
YOY-10.3%-11.2%+0.9%
3Y-12.5%-12.0%-0.5%
5Y-15.3%-11.7%-3.6%
10Y-15.3%-13.8%-1.5%
4.3.1.3. Return on Equity

Shows how efficient Vera Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • -16.3% Return on Equity means Vera Therapeutics Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vera Therapeutics Inc:

  • The MRQ is -16.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-12.4%-3.9%
TTM-12.4%YOY-14.9%+2.5%
TTM-12.4%5Y-14.2%+1.8%
5Y-14.2%10Y-14.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-14.3%-2.0%
TTM-12.4%-15.2%+2.8%
YOY-14.9%-15.2%+0.3%
3Y-17.3%-16.8%-0.5%
5Y-14.2%-17.5%+3.3%
10Y-14.2%-19.6%+5.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vera Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vera Therapeutics Inc is operating .

  • Measures how much profit Vera Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--161.5%+161.5%
TTM--286.7%+286.7%
YOY--254.3%+254.3%
3Y--270.1%+270.1%
5Y--356.3%+356.3%
10Y--528.7%+528.7%
4.3.2.2. Operating Ratio

Measures how efficient Vera Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.929-1.929
TTM-2.934-2.934
YOY-2.982-2.982
3Y-3.799-3.799
5Y-4.893-4.893
10Y-6.841-6.841
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vera Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 16.92 means the company has $16.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 16.918. The company is very able to pay all its short-term debts. +2
  • The TTM is 21.007. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ16.918TTM21.007-4.089
TTM21.007YOY15.898+5.109
TTM21.0075Y15.103+5.904
5Y15.10310Y15.1030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.9183.480+13.438
TTM21.0073.736+17.271
YOY15.8984.133+11.765
3Y14.6814.591+10.090
5Y15.1035.762+9.341
10Y15.1036.154+8.949
4.4.3.2. Quick Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 31.85 means the company can pay off $31.85 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 31.851. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 39.035. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ31.851TTM39.035-7.184
TTM39.035YOY28.900+10.136
TTM39.0355Y22.536+16.499
5Y22.53610Y22.5360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ31.8512.930+28.921
TTM39.0353.192+35.843
YOY28.9003.990+24.910
3Y26.2174.381+21.836
5Y22.5365.837+16.699
10Y22.5366.540+15.996
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vera Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vera Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vera Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Vera Therapeutics Inc assets are financed with 19.1% credit (debt) and the remaining percentage (100% - 19.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.191. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.162. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.191TTM0.162+0.028
TTM0.162YOY0.262-0.100
TTM0.1625Y0.470-0.308
5Y0.47010Y0.4700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1910.339-0.148
TTM0.1620.359-0.197
YOY0.2620.334-0.072
3Y0.2360.341-0.105
5Y0.4700.349+0.121
10Y0.4700.379+0.091
4.5.4.2. Debt to Equity Ratio

Measures if Vera Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 23.5% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.235. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.197. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.197+0.039
TTM0.197YOY0.386-0.189
TTM0.1975Y0.252-0.055
5Y0.25210Y0.2520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2350.391-0.156
TTM0.1970.432-0.235
YOY0.3860.427-0.041
3Y0.3330.462-0.129
5Y0.2520.459-0.207
10Y0.2520.514-0.262
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vera Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -4.91 means the investor is paying $-4.91 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vera Therapeutics Inc:

  • The EOD is -5.492. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.912. Based on the earnings, the company is expensive. -2
  • The TTM is -10.747. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.492MRQ-4.912-0.580
MRQ-4.912TTM-10.747+5.835
TTM-10.747YOY-15.453+4.706
TTM-10.7475Y-14.114+3.367
5Y-14.11410Y-14.1140.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.492-2.542-2.950
MRQ-4.912-2.355-2.557
TTM-10.747-2.660-8.087
YOY-15.453-3.770-11.683
3Y-10.420-3.843-6.577
5Y-14.114-6.412-7.702
10Y-14.114-7.084-7.030
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vera Therapeutics Inc:

  • The EOD is -7.641. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.834. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.543. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.641MRQ-6.834-0.806
MRQ-6.834TTM-10.543+3.709
TTM-10.543YOY-15.722+5.179
TTM-10.5435Y-18.661+8.117
5Y-18.66110Y-18.6610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.641-3.327-4.314
MRQ-6.834-3.016-3.818
TTM-10.543-3.645-6.898
YOY-15.722-4.377-11.345
3Y-13.099-5.257-7.842
5Y-18.661-8.487-10.174
10Y-18.661-9.626-9.035
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vera Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.21 means the investor is paying $3.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vera Therapeutics Inc:

  • The EOD is 3.590. Based on the equity, the company is fair priced.
  • The MRQ is 3.211. Based on the equity, the company is fair priced.
  • The TTM is 5.128. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.590MRQ3.211+0.379
MRQ3.211TTM5.128-1.917
TTM5.128YOY7.888-2.760
TTM5.1285Y8.230-3.102
5Y8.23010Y8.2300.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.5902.201+1.389
MRQ3.2112.007+1.204
TTM5.1282.189+2.939
YOY7.8882.409+5.479
3Y7.6182.558+5.060
5Y8.2303.764+4.466
10Y8.2304.462+3.768
4.6.2. Total Gains per Share

2.4. Latest News of Vera Therapeutics Inc

Does Vera Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Vera Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-10
22:04
Vera Therapeutics (VERA) Stock Surges 27% Over Last MonthRead
2025-09-05
22:05
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Read
2025-09-05
22:05
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vera Therapeutics Inc.

4.8.1. Institutions holding Vera Therapeutics Inc

Institutions are holding 109.933% of the shares of Vera Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30venBio Select Advisor LLC9.87092.5993630000059810010.4895
2025-06-30T. Rowe Price Associates, Inc.7.01890.0124479717-275115-5.786
2025-03-31BlackRock Inc6.25560.0023992537510511.2952
2025-06-30Kynam Capital Management, LP5.36938.69253426887102688742.787
2025-06-30Deerfield Management Co5.24591.431733481172298117218.8683
2025-03-31FMR Inc5.06450.00532323191791935.8692
2025-06-30Vanguard Group Inc4.70220.00113001108826852.8332
2025-06-30Sofinnova Ventures4.37774.026279398700
2025-06-30Woodline Partners LP4.08680.324626083721607523160.6159
2025-03-31Vestal Point Capital LP3.9174.288325000001425000132.5581
2025-06-30Eversept Partners, LLC3.73385.1641238305548425125.5029
2025-03-31State Street Corp3.26380.00212083048566962.7979
2025-06-30TANG CAPITAL MANAGEMENT LLC2.11521.607713500001200000800
2025-03-31ING Investment Management LLC1.96590.0168125471455962380.5108
2025-03-31Geode Capital Management, LLC1.88460.00231202809494844.2906
2025-06-30Integral Health Asset Management, LLC1.80182.4805115000000
2025-03-31Deutsche Bank AG1.39890.00858928598248310.1784
2025-06-30COMMODORE CAPITAL LP1.25351.3304800000-1761782-68.7717
2025-06-30Pictet Asset Manangement SA1.21090.0185772814-67444-8.0266
2025-06-30American Century Companies Inc1.11940.009271442833697889.2775
Total 75.656632.022648286771+7933730+16.4%

4.9.2. Funds holding Vera Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30T. Rowe Price New Horizons2.44550.2451560786-35824-2.2438
2025-06-30US Small-Cap Growth II Equity Comp2.44550.2451560786-117374-6.9942
2025-07-31Vanguard Total Stock Mkt Idx Inv2.35520.00161503184-33337-2.1696
2025-07-31iShares Russell 2000 ETF1.8950.04151209482-22995-1.8658
2025-06-30Fidelity Growth Compy Commingled Pl S1.86330.0301118925010670.0898
2025-06-30T. Rowe Price Health Sciences1.8330.24371169913293802.576
2025-06-30Fidelity Growth Company Fund1.38510.030288399600
2025-07-31SPDR® S&P Biotech ETF1.37570.3798877998262643.0836
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.93260.0154595204-255411-30.0266
2025-06-30American Century Small Cap Growth Inv0.88390.287656415326813390.5794
2025-06-30American Century U.S. Small Cap Growth0.88390.288456415326813390.5794
2025-07-31International Biotechnology Ord0.80233.262151207013932137.3766
2025-06-30T. Rowe Price New Horizons Tr-A0.79050.253250451479621.6035
2025-05-31Fidelity Small Cap Index0.71920.035459002-509-0.1108
2025-07-31iShares Russell 2000 Growth ETF0.70990.080645308500
2025-06-30Fidelity Select Biotechnology0.69620.2795444325-12700-2.7788
2025-06-30T. Rowe Price Integrated US Sm Gr Eq0.65710.1239419381-133400-24.1325
2025-06-30T. Rowe Price Integrated US SmCapGrEq0.65710.1239419381-101300-19.4553
2025-05-31Pictet-Biotech P USD0.61250.658839091247851.2392
2025-07-31Xtrackers S&P 500 Swap ETF 1C0.47470.0630298600
Total 24.41826.685315584561+32195+0.2%

5.3. Insider Transactions

Insiders are holding 3.963% of the shares of Vera Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-24Patrick G EnrightBUY4060722.35
2025-06-23Patrick G EnrightBUY20939320.87
2025-01-08Marshall FordyceSELL1750041.74
2024-12-18Marshall FordyceSELL1750043.07
2024-12-11Marshall FordyceSELL1750046.94
2024-10-28Beth C SeidenbergSELL1500048.03
2024-10-23Marshall FordyceSELL1937540.39
2024-10-09Marshall FordyceSELL1562538.24
2024-09-25Marshall FordyceSELL2312546.05
2024-09-18Beth C SeidenbergSELL117742.01
2024-09-11Marshall FordyceSELL1562537.5
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets578,528
Total Liabilities110,251
Total Stockholder Equity468,277
 As reported
Total Liabilities 110,251
Total Stockholder Equity+ 468,277
Total Assets = 578,528

Assets

Total Assets578,528
Total Current Assets567,651
Long-term Assets10,877
Total Current Assets
Cash And Cash Equivalents 49,121
Short-term Investments 507,706
Net Receivables 4,202
Other Current Assets 6,622
Total Current Assets  (as reported)567,651
Total Current Assets  (calculated)567,651
+/-0
Long-term Assets
Property Plant Equipment 3,622
Long-term Assets Other 7,255
Long-term Assets  (as reported)10,877
Long-term Assets  (calculated)10,877
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities33,554
Long-term Liabilities76,697
Total Stockholder Equity468,277
Total Current Liabilities
Short-term Debt 855
Accounts payable 13,157
Other Current Liabilities 19,542
Total Current Liabilities  (as reported)33,554
Total Current Liabilities  (calculated)33,554
+/-0
Long-term Liabilities
Long term Debt 74,464
Capital Lease Obligations Min Short Term Debt2,233
Long-term Liabilities  (as reported)76,697
Long-term Liabilities  (calculated)76,697
+/-0
Total Stockholder Equity
Common Stock64
Retained Earnings -589,475
Accumulated Other Comprehensive Income 527
Other Stockholders Equity 1,057,161
Total Stockholder Equity (as reported)468,277
Total Stockholder Equity (calculated)468,277
+/-0
Other
Capital Stock64
Cash and Short Term Investments 556,827
Common Stock Shares Outstanding 63,789
Liabilities and Stockholders Equity 578,528
Net Debt 28,431
Net Invested Capital 542,741
Net Working Capital 537,800
Property Plant and Equipment Gross 3,622
Short Long Term Debt Total 77,552



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
54,554
51,825
97,647
91,167
83,748
164,974
148,782
131,370
131,435
209,604
195,178
175,618
175,546
419,356
397,291
368,560
655,681
610,167
578,528
578,528610,167655,681368,560397,291419,356175,546175,618195,178209,604131,435131,370148,782164,97483,74891,16797,64751,82554,554000
   > Total Current Assets 
3,229
0
0
54,261
51,532
95,876
89,760
82,537
157,743
142,338
124,982
125,698
204,449
190,614
171,620
165,543
407,923
389,503
364,131
651,218
606,076
567,651
567,651606,076651,218364,131389,503407,923165,543171,620190,614204,449125,698124,982142,338157,74382,53789,76095,87651,53254,261003,229
       Cash And Cash Equivalents 
-3,229
0
0
53,654
49,505
91,625
86,191
79,674
111,506
50,427
30,475
43,459
137,385
33,889
27,441
45,681
69,105
25,085
27,256
92,646
55,090
49,121
49,12155,09092,64627,25625,08569,10545,68127,44133,889137,38543,45930,47550,427111,50679,67486,19191,62549,50553,65400-3,229
       Short-term Investments 
6,458
0
0
86
67
85
57
867
39,432
81,501
83,945
71,194
59,768
147,132
132,498
115,035
334,559
359,302
326,053
548,206
534,744
507,706
507,706534,744548,206326,053359,302334,559115,035132,498147,13259,76871,19483,94581,50139,43286757856786006,458
       Net Receivables 
0
0
0
52
0
0
0
0
0
0
0
0
0
0
0
0
1,631
1,960
1,997
3,773
3,586
4,202
4,2023,5863,7731,9971,9601,63100000000000052000
       Other Current Assets 
0
0
0
555
2,027
4,251
3,569
2,863
6,805
10,410
10,562
11,045
7,296
9,593
11,681
11,307
11,075
8,400
10,822
6,593
12,656
6,622
6,62212,6566,59310,8228,40011,07511,30711,6819,5937,29611,04510,56210,4106,8052,8633,5694,2512,027555000
   > Long-term Assets 
-3,229
0
0
293
293
1,771
1,407
1,211
7,231
6,444
6,388
5,737
5,155
4,564
3,998
10,003
11,433
7,788
4,429
4,463
4,091
10,877
10,8774,0914,4634,4297,78811,43310,0033,9984,5645,1555,7376,3886,4447,2311,2111,4071,77129329300-3,229
       Property Plant Equipment 
0
0
0
0
0
0
0
0
6,291
5,745
5,824
5,224
4,594
4,070
3,481
3,041
2,513
2,084
4,289
4,332
3,977
3,622
3,6223,9774,3324,2892,0842,5133,0413,4814,0704,5945,2245,8245,7456,29100000000
       Long Term Investments 
0
0
0
0
0
1,478
1,114
867
580
324
122
58
57
29
13
0
0
0
0
0
0
0
0000000132957581223245808671,1141,47800000
       Long-term Assets Other 
-3,229
0
0
293
293
293
293
344
360
375
442
455
504
465
504
6,951
8,920
5,704
140
131
114
7,255
7,2551141311405,7048,9206,95150446550445544237536034429329329329300-3,229
> Total Liabilities 
0
0
0
143,902
145,141
5,492
5,690
14,156
30,549
27,278
25,652
54,527
51,895
54,655
51,911
73,861
65,814
69,422
79,502
78,526
75,168
110,251
110,25175,16878,52679,50269,42265,81473,86151,91154,65551,89554,52725,65227,27830,54914,1565,6905,492145,141143,902000
   > Total Current Liabilities 
0
0
0
2,406
3,753
3,771
4,042
7,690
19,969
17,279
15,920
25,600
23,529
26,835
24,621
22,303
14,543
18,418
26,464
25,371
21,894
33,554
33,55421,89425,37126,46418,41814,54322,30324,62126,83523,52925,60015,92017,27919,9697,6904,0423,7713,7532,406000
       Short-term Debt 
0
0
0
2
0
0
0
0
4,980
4,900
5,378
2,645
5,204
5,120
5,036
4,872
2,275
4,232
1,872
1,483
1,191
855
8551,1911,4831,8724,2322,2754,8725,0365,1205,2042,6455,3784,9004,98000002000
       Accounts payable 
0
0
0
909
1,440
1,723
964
1,385
7,328
7,084
7,012
11,991
5,326
13,280
12,300
11,118
5,209
4,664
4,602
7,665
9,262
13,157
13,1579,2627,6654,6024,6645,20911,11812,30013,2805,32611,9917,0127,0847,3281,3859641,7231,440909000
       Other Current Liabilities 
0
0
0
1,495
2,313
2,048
3,078
6,305
7,661
5,295
3,530
10,964
12,999
8,435
7,285
6,313
7,059
9,522
19,990
16,223
11,441
19,542
19,54211,44116,22319,9909,5227,0596,3137,2858,43512,99910,9643,5305,2957,6616,3053,0782,0482,3131,495000
   > Long-term Liabilities 
0
0
0
141,496
141,388
1,721
1,648
6,466
10,580
9,999
9,732
28,927
28,366
27,820
27,290
51,558
51,271
51,004
53,038
53,155
53,274
76,697
76,69753,27453,15553,03851,00451,27151,55827,29027,82028,36628,9279,7329,99910,5806,4661,6481,721141,388141,496000
       Long term Debt Total 
0
0
0
0
0
0
0
4,923
4,937
4,952
4,966
24,810
24,886
0
0
0
0
0
0
0
0
0
00000000024,88624,8104,9664,9524,9374,9230000000
       Warrants
0
0
0
0
139,576
139,576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000139,576139,5760000
       Other Liabilities 
0
0
0
1,920
1,812
1,721
1,648
1,543
286
286
286
286
0
287
0
0
0
0
0
0
0
0
0000000028702862862862861,5431,6481,7211,8121,920000
> Total Stockholder Equity
3,547
0
0
-89,348
-93,316
92,155
85,477
69,592
134,425
121,504
105,718
76,908
157,709
140,523
123,707
101,685
353,542
327,869
289,058
577,155
534,999
468,277
468,277534,999577,155289,058327,869353,542101,685123,707140,523157,70976,908105,718121,504134,42569,59285,47792,155-93,316-89,348003,547
   Common Stock
0
0
0
0
0
21
21
21
27
27
28
28
44
44
44
44
54
55
55
64
64
64
646464555554444444442828272721212100000
   Retained Earnings -589,475-512,944-461,250-417,825-371,193-337,485-309,102-283,447-263,343-243,181-213,112-180,673-155,994-141,141-124,056-107,209-99,598-96,161-91,447000
   Capital Surplus 
0
0
0
0
2,845
2,845
192,665
193,627
275,551
277,623
286,642
290,216
400,850
0
0
0
0
0
0
0
0
0
000000000400,850290,216286,642277,623275,551193,627192,6652,8452,8450000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
-137,477
2,845
191,732
283,832
193,627
275,551
277,623
286,642
290,216
400,850
403,964
407,185
410,492
691,146
699,457
705,784
1,037,948
1,047,225
1,057,161
1,057,1611,047,2251,037,948705,784699,457691,146410,492407,185403,964400,850290,216286,642277,623275,551193,627283,832191,7322,845-137,477000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-167,170
Operating Income-167,170-167,170
 
Operating Expense (+$)
Research Development126,172
Selling General Administrative40,998
Selling And Marketing Expenses0
Operating Expense167,170167,170
 
Net Interest Income (+$)
Interest Income20,714
Interest Expense-7,626
Other Finance Cost-0
Net Interest Income13,088
 
Pretax Income (+$)
Operating Income-167,170
Net Interest Income13,088
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-152,147-182,193
EBIT - interestExpense = -167,399
-152,147
-144,522
Interest Expense7,626
Earnings Before Interest and Taxes (EBIT)-159,773-144,521
Earnings Before Interest and Taxes (EBITDA)-167,170
 
After tax Income (+$)
Income Before Tax-152,147
Tax Provision-1
Net Income From Continuing Ops-152,148-152,148
Net Income-152,148
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net15,023-13,088
 

Technical Analysis of Vera Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vera Therapeutics Inc. The general trend of Vera Therapeutics Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vera Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Vera Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vera Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 31.77 < 32.65 < 33.00.

The bearish price targets are: 25.30 > 25.29 > 23.81.

Know someone who trades $VERA? Share this with them.👇

Vera Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vera Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vera Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vera Therapeutics Inc. The current macd is 0.87470419.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vera Therapeutics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vera Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vera Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartVera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vera Therapeutics Inc. The current adx is 15.26.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vera Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Vera Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vera Therapeutics Inc. The current sar is 22.77.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vera Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vera Therapeutics Inc. The current rsi is 66.56. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Vera Therapeutics Inc Daily Relative Strength Index (RSI) ChartVera Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vera Therapeutics Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vera Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vera Therapeutics Inc Daily Stochastic Oscillator ChartVera Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vera Therapeutics Inc. The current cci is 146.48.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Vera Therapeutics Inc Daily Commodity Channel Index (CCI) ChartVera Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vera Therapeutics Inc. The current cmo is 41.88.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartVera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vera Therapeutics Inc. The current willr is -1.34357006.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Vera Therapeutics Inc Daily Williams %R ChartVera Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vera Therapeutics Inc.

Vera Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vera Therapeutics Inc. The current atr is 1.20654413.

Vera Therapeutics Inc Daily Average True Range (ATR) ChartVera Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vera Therapeutics Inc. The current obv is 27,616,910.

Vera Therapeutics Inc Daily On-Balance Volume (OBV) ChartVera Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vera Therapeutics Inc. The current mfi is 70.29.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Vera Therapeutics Inc Daily Money Flow Index (MFI) ChartVera Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vera Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-28STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Vera Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.558
Ma 20Greater thanMa 5023.452
Ma 50Greater thanMa 10022.446
Ma 100Greater thanMa 20022.654
OpenGreater thanClose25.070
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vera Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Vera Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vera Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vera Therapeutics Inc

I send you an email if I find something interesting about Vera Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Vera Therapeutics Inc.

Receive notifications about Vera Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.